Combining Low-Dose Post-Transplant Cyclophosphamide(PTCY) with Anti-Thymocyte Globulin( ATG) for Prophylaxis of Graft-Versus-Host Disease in Alternative-Donor Hematopoietic Stem Cell Transplantation for β-Thalassemia Major

被引：0

作者：

Lu, Jingyuan ^{[1
]}

Zhuang, Yanhong ^{[1
]}

Hong, Xiuli ^{[1
]}

Chen, Jie ^{[1
]}

Chen, Yanxin ^{[1
]}

Jiang, Erlie ^{[2
,3
]}

Lu, Quanyi ^{[1
]}

机构：

[1] Xiamen Univ, Zhongshan Hosp, Dept Hemotol, Xiamen, Peoples R China

[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186196

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
Ruggeri, Annalisa
Sun, Yuqian
Labopin, Myriam
Bacigalupo, Andrea
Lorentino, Francesca
Arcese, William
Santarone, Stella
Gulbas, Zafer
Blaise, Didier
Messina, Giuseppe
Ghavamzadeh, Ardeshi
Malard, Florent
Bruno, Benedetto
Diez-Martin, Jose Luis
Koc, Yener
Ciceri, Fabio
Mohty, Mohamad
Nagler, Arnon
HAEMATOLOGICA, 2017, 102 (02) : 401 - 410
[2] PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia
Dalal, Prarthana
Dalal, Jignesh
LEUKEMIA & LYMPHOMA, 2024, 65 (12) : 1747 - 1748
[3] Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant
Bryant, Adam
Mallick, Ranjeeta
Huebsch, Lothar B.
Allan, David S.
Atkins, Harold
Anstee, Grizel
Bence-Bruckler, Isabelle
Hamelin, Linda
Hodgins, Michael
Sabloff, Mitchell
Scrivens, Nicholas
Maze, Dawn C.
Bredeson, Christopher N.
Kekre, Natasha
BLOOD, 2016, 128 (22)
[4] Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant
Bryant, Adam
Mallick, Ranjeeta
Huebsch, Lothar B.
Allan, David S.
Atkins, Harold
Anstee, Grizel
Bence-Bruckler, Isabelle
Hamelin, Linda
Hodgins, Michael
Sabloff, Mitchell
Scrivens, Nicholas
Maze, Dawn
Bredeson, Christopher N.
Kekre, Natasha
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S310 - S311
[5] Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
Xu, Xiaoqian
Yang, Jun
Cai, Yu
Li, Su
Niu, Jiahua
Zhou, Kun
Jiang, Ying
Xu, Xiaowei
Shen, Chang
Huang, Chongmei
Qiu, Huiying
Wei, Daolin
Kang, Mei
Tong, Yin
Wei, Zheng
Liu, Peng
Wan, Liping
Song, Xianmin
BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 705 - 708
[6] Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
Xiaoqian Xu
Jun Yang
Yu Cai
Su Li
Jiahua Niu
Kun Zhou
Ying Jiang
Xiaowei Xu
Chang Shen
Chongmei Huang
Huiying Qiu
Daolin Wei
Mei Kang
Yin Tong
Zheng Wei
Peng Liu
Liping Wan
Xianmin Song
Bone Marrow Transplantation, 2021, 56 : 705 - 708
[7] Low-Dose Antithymocyte Globulin, Post-Transplant Cyclophosphamide and Sirolimus As Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Transplants
Greco, Raffaella
Peccatori, Jacopo
Crucitti, Lara
Vago, Luca
Cieri, Nicoletta
Giglio, Fabio
Stanghellini, Maria Teresa Lupo
Morelli, Mara
Barbanti, Maria Chiara
Piemontese, Simona
Perini, Tommaso
Sala, Elisa
Pavesi, Francesca
Messina, Carlo
Milani, Raffaella
Marcatti, Magda
Marktel, Sarah
Carrabba, Matteo G.
Bernardi, Massimo
Corti, Consuelo
Assanelli, Andrea
Bonini, Chiara
Ciceri, Fabio
BLOOD, 2015, 126 (23)
[8] Low-dose antithymocyte globulin, post-transplant cyclophosphamide and sirolimus as graft-versus-host disease prophylaxis in unrelated donor transplants
Greco, R.
Crucitti, L.
Vago, L.
Cieri, N.
Giglio, F.
Stanghellini, M. T. Lupo
Morelli, M.
Barbanti, M. C.
Piemontese, S.
Perini, T.
Sala, E.
Pavesi, F.
Messina, C.
Milani, R.
Marcatti, M.
Marktel, S.
Carrabba, M.
Bernardi, M.
Corti, C.
Assanelli, A.
Bonini, C.
Ciceri, F.
Peccatori, J.
BONE MARROW TRANSPLANTATION, 2016, 51 : S438 - S439
[9] POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) VERSUS ANTI-THYMOCYTE GLOBULIN (ATG) VERSUS COMBINATION FOR GRAFT-VERSUS-HOST DISEASE PREVENTION IN HAPLOIDENTICAL TRANSPLANTATION FOR ADULT ACUTE MYELOID LEUKEMIA: A REPORT FROM THE EBMT
Bazarbachi, Abdul-Hamid
Labopin, Myriam
Angelucci, Emanuele
Blaise, Didier
Ciceri, Fabio
Arcese, William
Santarone, Stella
Koc, Yener
Bramanti, Stefania
Kulagin, Alexander
Kwon, Mi
Sica, Simona
Sanz, Jaime
Brissot, Eolia
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 64 - 65
[10] Effective Strategy to Prevent Acute Graft-Versus-Host Disease in Unrelated Donor Allogeneic Hematopoietic Cell Transplants By Using a Combination of Anti-Thymocyte Globulin (ATG), Post-Transplant Cyclophosphamide and Cyclosporine
Deotare, Uday
Loach, David
Michelis, Fotios V.
Kim, Dennis D.
Thyagu, Santhosh
Lipton, Jeffrey H.
Messner, Hans A.
Viswabandya, Auro
BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →